SFX by Ex Libris Inc.

Title:	Expression of human α1 antitrypsin in transgenic sheep
Source:	Cytotechnology [0920-9069] Carver, A yr:1992

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Karnaukhova, E. "Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use." Amino acids 30.4 (2006): 317-32.
description	2.	Paleyanda RK, R K K. "Transgenic pigs produce functional human factor VIII in milk." Nature biotechnology 15.10 (1997): 971-5.
description	3.	Turecek, P. "Biochemical, molecular characterization, and glycoproteomic analyses of α1-proteinase inhibitor products used for replacement therapy." Transfusion 46.11 (2006): 1959-77.
description	4.	"Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects." Genome biology 18.1: 13-13.
description	5.	Miao, H Z. "28 Development of Milk-Targeted Transgenic Animals Expressing Coagulation Factor VIII Bioengineered for High Efficiency Secretion." Pediatric research 60.4 (2006): 495-495.
description	6.	Knight, K R R. "The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema." Respirology 2.2 (1997): 91-5.
description	7.	Hubbard, R. "Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route." Lung 168.1 (1990): 565-78.
description	8.	Soukharev, S. "Expression of factor VIII in recombinant and transgenic systems." Blood cells, molecules & diseases 28.2 (2002): 234-48.
description	9.	Velander, T. "Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide." Haemophilia 10.s4: 70-6.
description	10.	Chen, H. "Improvement of glycosylation in insect cells with mammalian glycosyltransferases." Journal of biotechnology 102.1 (2003): 61-71.
description	11.	Sodoyer, R. "Expression systems for the production of recombinant pharmaceuticals." BioDrugs 18.1 (2004): 51-62.
description	12.	Torossi, T. "Endomannosidase processes oligosaccharides of alpha 1-antitrypsin and its naturally occurring genetic variants in the Golgi apparatus." Cellular and molecular life sciences 63.16 (2006): 1923-1932.
description	13.	Griffiths, Steven W W. "Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin." Biochemistry 41.20 (2002): 6245-52.
description	14.	Boedeker, B G G. "Production processes of licensed recombinant factor VIII preparations." Seminars in thrombosis and hemostasis 27.4 (2001): 385-94.
description	15.	Segers, K. "Design of protein-membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V." Proceedings of the National Academy of Sciences of the United States of America 104.31 (2007): 12697-12702.
description	16.	Pastan, I. "Immunotoxin treatment of cancer." Annual review of medicine 58.1 (2007): 221-237.
description	17.	"Improvements in Gene Editing Technology Boost Its Applications in Livestock." Frontiers in genetics. 11: 614688-614688.
description	18.	Li, Ze. "Generation of tryptophan hydroxylase 2 gene knockout pigs byCRISPR/Cas9-mediated gene targeting." The Journal of Biomedical Research 31.5 (2017): 445-452.
description	19.	Grupen, Christopher G. "Effects of milrinone and butyrolactone-I on porcine oocyte meiotic progression and developmental competence." Reproduction, fertility and development 18.3 (2006): 309-317.
description	20.	Mathias, D K. "Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-based Malaria Transmission-blocking Recombinant Vaccine." Infection and immunity 80.4 (2012): 1606-1614.